Charles D. Emery, Ph.D., MBA, is a medical device executive, innovator, and ultrasound

technology leader with more than 25 years of experience developing and commercializing

diagnostic and therapeutic ultrasound systems. Throughout his career, he has successfully

translated novel research concepts into clinically impactful products by combining deep

technical expertise in system architecture, signal processing, transducer design, imaging,

therapy, and intellectual property development with strong business and product leadership.

He is an inventor on dozens of issued and pending patents spanning ultrasound imaging,

therapeutic ultrasound, medical aesthetics, cardiovascular therapy, and medical device

systems.

Dr. Emery is currently Senior Engineering Director at Sciton, Inc. in Palo Alto, California, where

he leads the development of next-generation ultrasound-based platforms and advanced energy

technologies for medical aesthetics. Previously, he served as Vice President of Product

Development and Chief Innovation Officer at Ulthera, Inc., where he led multidisciplinary teams

responsible for developing and commercializing advanced ultrasound systems that contributed

to Ulthera’s acquisition by Merz for $600 million. His experience spans startups, growth-stage

companies, and multinational medical device organizations, providing a unique perspective on

the challenges of translating innovation into commercial success. His work has included product

strategy, system architecture, preclinical and clinical development, design controls, regulatory

submissions, intellectual property creation, and global commercialization.

In addition to executive leadership roles, Dr. Emery has served as a consultant, advisor, and

technical architect for numerous medical technology companies, including Method AI,

EndoSound, Daxsonics, Moonrise Medical, Beluga Medical, Deep Breathe Medical, and Ardian,

where his contributions supported technology development, product strategy,

commercialization, and corporate growth initiatives. He has also served as an Adjunct Professor

at Dalhousie University and as a Technical Program Committee Member for the IEEE

International Ultrasonics Symposium. Dr. Emery holds a Ph.D. in Biomedical Engineering from

Duke University and an MBA in Technology Management from the University of Washington,

graduating summa cum laude and first in class. He is passionate about mentoring innovators

and helping bridge the gap between academic research and successful medical device

commercialization.